Exact Mass: 459.10293400000006
Exact Mass Matches: 459.10293400000006
Found 100 metabolites which its exact mass value is equals to given mass value 459.10293400000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate
4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate
Narceinone
Narceinone is found in opium poppy. Narceinone is an alkaloid from unlanced dried capsules of Papaver somniferum (opium poppy). Alkaloid from unlanced dried capsules of Papaver somniferum (opium poppy). Narceinone is found in opium poppy.
1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate
Trace metabolite of corn. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. Trace metabolite of corn.
4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-glucopyranoside
Analogue A
C23H23Cl2N3O3 (459.11163880000004)
Lilly 117018
C27H25NO4S (459.15042100000005)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists
Mivebresib
C22H19F2N3O4S (459.10642780000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
6-hydroxy-galanthindole 6-O-beta-D-glucopyranoside|6-hydroxy-galanthindolyloside A
Phe-Trp-OH
C25H21N3O6 (459.14302860000004)
1-(2-Hydroxyphenylamino)-1-deoxy-b-D-gentiobioside 1,2-carbamate
Narceinone
5-Methyl-7-[3-(trifluoromethyl)phenyl]-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine
C22H20F3N5O3 (459.1518166000001)
2-Propanol,1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-, hydrochloride(1:2)
C21H28Cl3N3O2 (459.12469980000003)
Benzyl N-N-phenylmethoxycarbonyl-N
C18H16F3N3O6S (459.07118720000005)
(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one
[4-(2,4-difluorophenyl)-2-[(4-methoxyphenyl)carbamoyl]phenyl] benzoate
C27H19F2NO4 (459.12820780000004)
(+/-)-n,n-dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine monohydrate
Flurazepam hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
AZD-3759
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Nitrocycline
C21H21N3O9 (459.12777360000007)
C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide
Mivebresib
C22H19F2N3O4S (459.10642780000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
wogonin 7-O-beta-D-glucuronate
C22H19O11- (459.09273240000005)
The monocarboxylic acid anion that is the conjugate base of wogonin 7-O-beta-D-glucuronide.
oroxylin A 7-O-beta-D-glucuronate
C22H19O11- (459.09273240000005)
The monocarboxylic acid anion that is the conjugate base of oroxylin A 7-O-beta-D-glucuronide.
4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc
(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide
C23H23Cl2N3O3 (459.11163880000004)
[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate
4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine
(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide
(Z)-4-(1,3-benzothiazol-2-yl)-5-[4-(N-methylanilino)-3-nitrophenyl]-4-pentenoic acid
C25H21N3O4S (459.1252706000001)
N-{2-[4-(4-chlorobenzoyl)-1-piperazinyl]phenyl}-1-benzofuran-2-carboxamide
(2E)-3-[5-(4-bromophenyl)furan-2-yl]-2-cyano-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
3-(4-Butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester
C23H23ClFN3O4 (459.13610400000005)
4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester
C21H21N3O7S (459.11001560000005)
5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide
C21H18ClN3O5S (459.06556480000006)
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide
beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S
(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C21H22BrN3O4 (459.07935920000006)
2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose
(5-fluoro-2,4-dioxo-1H-pyrimidin-6-yl) 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate
(S)-2-(4-Chlorophenyl)-2-Pyridin-3-Yl-1-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-Yl]ethanone
C24H21ClF3N3O (459.13251620000005)
2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose
2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose
7-methyl-7,8-dihydroguanosine-5-diphosphate
A purine ribonucleoside 5-diphosphate having 7-methyl-7,8-dihydroguanine as the nucleobase.
Lilly 117018
C27H25NO4S (459.15042100000005)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists
1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate
KG5
C20H16F3N7OS (459.10890820000003)
KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities[1].
(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid
C17H21N3O12 (459.11251860000004)
12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one
(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid
C17H21N3O12 (459.11251860000004)
1-(2-hydroxyphenylamino)-1-deoxy-β-gentio-bioside 1,2-carbamate
{"Ingredient_id": "HBIN000886","Ingredient_name": "1-(2-hydroxyphenylamino)-1-deoxy-\u03b2-gentio-bioside 1,2-carbamate","Alias": "NA","Ingredient_formula": "C19H25NO12","Ingredient_Smile": "C1=CC=C(C(=C1)N2C3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,4ar,12bs)-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-3-[(1r,2r)-1-methylaziridin-2-yl]-2,4,4a,5-tetrahydrotetraphene-1,6-dione
8-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid
4,11,24,25-tetrahydroxy-25-(1-hydroxyethyl)-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione
C26H21NO7 (459.13179560000003)
8-{[(2s)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid
(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-(1h-pyrrole-2-carbonyloxy)-6-[(1h-pyrrole-2-carbonyloxy)methyl]oxan-2-yl 1h-pyrrole-2-carboxylate
C21H21N3O9 (459.12777360000007)
(1r,17s,24s,25r)-4,11,24,25-tetrahydroxy-25-[(1r)-1-hydroxyethyl]-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione
C26H21NO7 (459.13179560000003)
(2r,3s,5s,6s)-6-{[(3s,3ar)-7-chloro-5-(cyanomethyl)-3-hydroxy-3h-cyclopenta[a]inden-3a-yl]oxy}-5-hydroxy-2,3-dimethyl-4-oxooxan-3-yl acetate
C23H22ClNO7 (459.10847320000005)